
Simon Michel, Ypsomed CEO: “There is a large pool of qualified people in Barcelona”
24 May 2022
Business Investments · Life Sciences
The Swiss medtech company Ypsomed is a world leader in manufacturing insulin pens. Ypsomed has chosen Barcelona to open its first R&D center outside Switzerland and expects to build a workforce of 60 people over the next year.
CEO Simon Michel explains in this interview how, from Barcelona, the company will do everything that involves digitalizing its devices. Finding the best talent pool in Catalonia was a determining factor for the new investment, as well as sharing the same cultural values.
Simon Michel also highlights the support Ypsomed received from Catalonia Trade & Investment to find the right location and to undergo the recruiting process.
Interested in investing in Barcelona - Catalonia?
We are the one-stop shop for international companies looking to establish or expand their operations in Catalonia. Contact us and we will help you grow.
Check out our services.
-
Business Location Service
Get all the information about industrial buildings, land, business centers, or office spaces in Barcelona-Catalonia.
-
Access to talent
Access to all sources of available talent for international companies in Barcelona-Catalonia.
-
International Mobility for Executives
We will guide you through the international mobility process from start to finish.
More news and success stories
in Barcelona (Catalonia).
-
29 Sep 2025
Lidl launches €140M logistics platform in Barcelona, its biggest in Spain
-
22 Sep 2025
American company Digital Realty invests €230 million in a new Data Center in Barcelona
-
22 Sep 2025
HIPRA opens new €500M Biotech campus in Catalonia, strengthening Europe’s Life Sciences hub
-
19 Sep 2025
APM Terminals invests €156 million in Barcelona to boost Mediterranean logistics hub